Fig. 1 · Structure

Documents & Downloads

Methyl Hesperidin

Cat. No. A10581 CAS 11013-97-1
Methyl Hesperidin is a compound of the vitamin P group

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
Akt
PKC

Methyl Hesperidin Research Summary

This section summarizes 2 in vitro studies of Methyl Hesperidin from 1 published reference.

Methyl Hesperidin In Vitro Studies

Methyl Hesperidin significantly caused a lethal effect in H9c2 cells after 24 h treatment, with an IC50 of 0.001745 mg/ml. In HepG2 cells, Methyl Hesperidin significantly caused a lethal effect after 24 h treatment, with an IC50 of 0.002395 mg/ml. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Methyl Hesperidin Effects on H9c2 Cell Survival

Cell-based study · H9c2; n = 9 [1]

In H9c2 cells, Methyl Hesperidin treatment for 24 h significantly caused a lethal effect, with an IC50 of 0.001745 mg/ml.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Survival rate of cellsIC50 IC50 of 0.001745 mg/ml[1]

Literature-Reported Treatment Conditions

Exposure duration
24 h treatment
Vehicle
ddH2O
Reported limits
Not stated in the sentences used: dose, route, control.
Methods and source locations

Compound reported in the paper: Methyl Hesperidin

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Materials and Methods > Animals and Drug Administration (S15); Results > Attribution of Individual Chemical Synthetic Drugs From NLTC on Cellular Toxicity (S93); Figure 7 legend (S152, S153, S155)

Survival rate of cells: Survival rate of cells — Results > Attribution of Individual Chemical Synthetic Drugs From NLTC on Cellular Toxicity (S93); Figure 7 legend (S152)

Methyl Hesperidin Effects on HepG2 Cell Survival

Cell-based study · HepG2; n = 9 [1]

In HepG2 cells, Methyl Hesperidin treatment for 24 h significantly caused a lethal effect, with an IC50 of 0.002395 mg/ml.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Survival rate of cellsIC50 IC50 of 0.002395 mg/ml[1]

Literature-Reported Treatment Conditions

Exposure duration
24 h treatment
Vehicle
ddH2O
Reported limits
Not stated in the sentences used: dose, route, control.
Methods and source locations

Compound reported in the paper: Methyl Hesperidin

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Materials and Methods > Animals and Drug Administration (S15); Results > Attribution of Individual Chemical Synthetic Drugs From NLTC on Cellular Toxicity (S93); Figure 7 legend (S152, S153, S155)

Survival rate of cells: Survival rate of cells — Results > Attribution of Individual Chemical Synthetic Drugs From NLTC on Cellular Toxicity (S93); Figure 7 legend (S152)

Specifications

Manufacturer Adooq Bioscience
CAS Number 11013-97-1
Formula C29H36O15
Molecular Weight 624.59
SMILES
C[C@@H]1[C@H]([C@@H]([C@@H]([C@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC(=C4C(=O)C[C@H](OC4=C3)C5=CC(=C(C=C5)OC)OC)O)O)O)O)O)O)O

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 93 mg/mL (148.89 mM)
Water 93 mg/mL (148.89 mM)
Ethanol Insoluble

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Methyl Hesperidin Research References

  1. [1] Liu X, Shao R, Yang X, et al. Untargeted Safety Pharmacology Screen of Blood-Activating and Stasis-Removing Patent Chinese Herbal Medicines Identified Nonherbal Ingredients as a Cause of Organ Damage in Experimental Models. Front Pharmacol (2019). PMID: 31607901 DOI: 10.3389/fphar.2019.00993 Source material

Added to your cart

View Cart Checkout
Loading...